Cargando…

Unveiling prognostics biomarkers of tyrosine metabolism reprogramming in liver cancer by cross-platform gene expression analyses

Tyrosine is mainly degraded in the liver by a series of enzymatic reactions. Abnormal expression of the tyrosine catabolic enzyme tyrosine aminotransferase (TAT) has been reported in patients with hepatocellular carcinoma (HCC). Despite this, aberration in tyrosine metabolism has not been investigat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Tran N., Nguyen, Ha Q., Le, Duc-Hau
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295234/ https://www.ncbi.nlm.nih.gov/pubmed/32542016 http://dx.doi.org/10.1371/journal.pone.0229276

Ejemplares similares

Gene Expression Analysis Reveals Prognostic Biomarkers of the Tyrosine Metabolism Reprogramming Pathway for Prostate Cancer
por: Li, Wei, et al.
Publicado: (2022)

Multi-Omics Analysis Detects Novel Prognostic Subgroups of Breast Cancer
por: Nguyen, Quang-Huy, et al.
Publicado: (2020)

Metabolic Reprogramming of Liver Fibrosis
por: Delgado, M. Eugenia, et al.
Publicado: (2021)

Prognostic performance of the Rapid Emergency Medicine Score (REMS) and Worthing Physiological Scoring system (WPS) in emergency department
por: Ha, Duc T, et al.
Publicado: (2015)

Development and validation of a prognostic model for predicting 30-day mortality risk in medical patients in emergency department (ED)
por: Ha, Duc T., et al.
Publicado: (2017)

Corrigendum: Development and validation of a prognostic model for predicting 30-day mortality risk in medical patients in emergency department (ED)
por: Ha, Duc T., et al.
Publicado: (2017)

Epigenetic and metabolic reprogramming in inflammatory bowel diseases: diagnostic and prognostic biomarkers in colorectal cancer
por: Deris Zayeri, Zeinab, et al.
Publicado: (2023)

Identification of Five Hub Genes as Key Prognostic Biomarkers in Liver Cancer via Integrated Bioinformatics Analysis
por: Nguyen, Thong Ba, et al.
Publicado: (2021)

Optical Properties of Doxorubicin Hydrochloride Load and Release on Silica Nanoparticle Platform
por: Nguyen, Trong Nghia, et al.
Publicado: (2021)

Unveiling the metabolic fate of monosaccharides in cell membranes with glycomic and glycoproteomic analyses
por: Xu, Gege, et al.
Publicado: (2019)

A sportomics soccer investigation unveils an exercise-induced shift in tyrosine metabolism leading to hawkinsinuria
por: França, Thássia Casado Lima, et al.
Publicado: (2023)

URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers
por: Ding, Zhiwen, et al.
Publicado: (2023)

Multi-omics analyses of glucose metabolic reprogramming in colorectal cancer
por: Huang, Maosen, et al.
Publicado: (2023)

Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology
por: Sogabe, Yuko, et al.
Publicado: (2018)

Attitudes towards Intimate Partner Violence against Women among Women and Men in 39 Low- and Middle-Income Countries
por: Tran, Thach Duc, et al.
Publicado: (2016)

Identification of CCDC115 as an adverse prognostic biomarker in liver cancer based on bioinformatics and experimental analyses
por: Su, Chang, et al.
Publicado: (2023)

Identification and Validation of a Novel Three Hub Long Noncoding RNAs With m6A Modification Signature in Low-Grade Gliomas
por: Nguyen, Quang-Huy, et al.
Publicado: (2022)

DrGA: cancer driver gene analysis in a simpler manner
por: Nguyen, Quang-Huy, et al.
Publicado: (2022)

In silico Approach for Validating and Unveiling New Applications for Prognostic Biomarkers of Endometrial Cancer
por: Coll-de la Rubia, Eva, et al.
Publicado: (2021)

Improving existing analysis pipeline to identify and analyze cancer driver genes using multi-omics data
por: Nguyen, Quang-Huy, et al.
Publicado: (2020)

oCEM: Automatic detection and analysis of overlapping co-expressed gene modules
por: Nguyen, Quang-Huy, et al.
Publicado: (2022)

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
por: Nguyen, Trang T. T., et al.
Publicado: (2022)

Unveiling the human nitroproteome: Protein tyrosine nitration in cell signaling and cancer
por: Griswold-Prenner, Irene, et al.
Publicado: (2023)

Vehicle Mode and Driving Activity Detection Based on Analyzing Sensor Data of Smartphones
por: Lu, Dang-Nhac, et al.
Publicado: (2018)

Resveratrol on the Metabolic Reprogramming in Liver: Implications for Advanced Atherosclerosis
por: Ma, Ying, et al.
Publicado: (2021)

Metabolism-Associated Epigenetic and Immunoepigenetic Reprogramming in Liver Cancer
por: Fan, Chaofan, et al.
Publicado: (2021)

Hypoxia, Metabolic Reprogramming, and Drug Resistance in Liver Cancer
por: Bao, Macus Hao-Ran, et al.
Publicado: (2021)

Numerical study of sediment scour at meander flume outlet of boxed culvert diversion work
por: Le, Hien T. T., et al.
Publicado: (2022)

Tyrosine metabolic reprogramming coordinated with the tricarboxylic acid cycle to drive glioma immune evasion by regulating PD‐L1 expression
por: Wang, Ji‐Yan, et al.
Publicado: (2023)

Metabolic engineering of a tyrosine-overproducing yeast platform using targeted metabolomics
por: Gold, Nicholas D., et al.
Publicado: (2015)

PDK4‐Deficiency Reprograms Intrahepatic Glucose and Lipid Metabolism to Facilitate Liver Regeneration in Mice
por: Zhao, Yulan, et al.
Publicado: (2020)

Electron delocalization in single-layer phthalocyanine-based covalent organic frameworks: a first principle study
por: Pham, Hung Q., et al.
Publicado: (2019)

Physical growth: is it a good indicator of development in early childhood in low- and middle-income countries?
por: Tran, Thach Duc, et al.
Publicado: (2019)

Multi-platform NMR Study of Pluripotent Stem Cells Unveils Complementary Metabolic Signatures towards Differentiation
por: Elena-Herrmann, Bénédicte, et al.
Publicado: (2020)

Transcriptomics unveils immune metabolic disruption and a novel biomarker of mortality in patients with HBV-related acute-on-chronic liver failure
por: Liang, Xi, et al.
Publicado: (2023)

Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic features
por: Li, Xiangchun, et al.
Publicado: (2018)

Immune–related biomarkers shared by inflammatory bowel disease and liver cancer
por: Nguyen, Thong Ba, et al.
Publicado: (2022)

Glucose Metabolism Reprogramming in Bladder Cancer: Hexokinase 2 (HK2) as Prognostic Biomarker and Target for Bladder Cancer Therapy
por: Afonso, Julieta, et al.
Publicado: (2023)

Re-Identification of Patient Subgroups in Uveal Melanoma
por: Nguyen, Thi Hai Yen, et al.
Publicado: (2021)

Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils Novel Prognostic Biomarkers in Multiple Myeloma
por: Zhao, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ap5jv6gcpjul0qrjkm06o40i1h